← Back to Search

Survivor-SHIP for Sleep Disorders

Waitlist Available
Led By Eric Zhou, PhD
Research Sponsored by Dana-Farber Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Child aged 5-12 years, with a history of a cancer diagnosis (except non-melanoma skin cancer).
No cancer therapy (excluding chemoprevention) in the past 6 months, and no further therapy planned.
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial is testing whether an educational program can help improve the sleep of children who have had sleep problems after cancer treatment.

Eligible Conditions
  • Sleep Disorders
  • Insomnia
  • Pediatric Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Intervention acceptability
Intervention feasibility
Secondary outcome measures
General quality of life
Screen time
Sleep change
+3 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Survivor-SHIPExperimental Treatment1 Intervention
Parents/guardians will take part in 3 education sessions over a one month period. During the sessions, they will learn more about common sleep problems following cancer treatment and ways to understand their child's unique patterns. They will then be educated about behavioral changes they can make to improve their child's sleep.
First Studied
Drug Approval Stage
How many patients have taken this drug

Find a Location

Who is running the clinical trial?

Dana-Farber Cancer InstituteLead Sponsor
1,078 Previous Clinical Trials
340,856 Total Patients Enrolled
Children's Cancer Research FundUNKNOWN
2 Previous Clinical Trials
132 Total Patients Enrolled
Eric Zhou, PhD4.941 ReviewsPrincipal Investigator - Dana-Farber Cancer Institute
Dana-Farber Cancer Institute
3 Previous Clinical Trials
97 Total Patients Enrolled
5Patient Review
I highly recommend Dr. Zhou if you're struggling to sleep. Before meeting him, I was taking all sorts of medication for sleep (Z-Quil, trazodone, Ambien, etc.) and it wasn't doing anything to help me. After just a few sessions with Dr. Zhou, my sleep schedule has completely changed. I now go to bed and fall asleep within 10 minutes, and I wake up feeling refreshed. He's a great listener and really knows his stuff when it comes to sleep. If you follow his advice, I promise you'll see a big difference.

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many people are involved in the research endeavor?

"Affirmative. Clinicaltrials.gov details reveal that this clinical trial, first posted on May 24th 2021, is actively recruiting patients at present time. The research requires twenty participants from a single medical facility to participate in the experiment."

Answered by AI

What goals have been set out for this medical experiment?

"This 6 week-long study will measure the acceptability of a given intervention. It also seeks to quantify the quality, habits, and changes in sleep of enrolled children via 3 secondary outcomes: The Patient-reported Outcomes Measurement Information System (PROMIS) Pediatric Sleep Scales; Children's Sleep Habits Questionnaire (CSHQ); and an assessment on whether any non-intervention advised alterations were made to their child's sleeping routine."

Answered by AI

Are there any opportunities for eligible individuals to participate in this research endeavor?

"Indeed, clinicaltrials.gov attests that this study is still actively recruiting applicants - it was initially posted on May 24th 2021 and last updated June 27th 2022. The trial seeks 20 individuals from one site to participate."

Answered by AI

Are octogenarians eligible to participate in this investigation?

"To be included in this research, patients need to be between 5 and 12 years old."

Answered by AI

Which demographic of individuals meets the criteria for participation in this research project?

"This trial is seeking 20 children between 5 and 12 years old that possess parasomnias. In addition, the following qualifications must be met: lack of cancer treatment in the past 6 months (excl.: chemoprevention), a history of a non-dermatological malignancy, insomnia disorder according to screening criteria (see Appendix A), parental/guardian literacy in English, availability of computer/smartphone with internet access at home."

Answered by AI
~4 spots leftby Apr 2025